Trial Profile
Clinical Trials Insight: 700036225
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Aug 2008
Price :
$35
*
At a glance
- Drugs Nicotine abuse vaccine (Primary)
- Indications Smoking withdrawal; Substance-related disorders
- Focus Therapeutic Use
- Sponsors Nabi Biopharmaceuticals
- 14 Aug 2008 New trial record.